Direct answer. A peptide production-base visit can be requested by a qualified business buyer, subject to a written appointment, site availability and access rules. A useful visit supports operating-site due diligence and workflow review, but it does not replace the specification, lot COA, independent testing or regulatory review.
Prepare the evidence path before the trip: align the product and lot question in the documentation map, review the available quality route, and check the commercial entity through the supplier-verification process. Use the appointment form only after the team has defined what it needs to review.
What should a peptide factory visit agenda include?
| Agenda item | What to confirm | Output to request |
|---|---|---|
| Opening and scope | Legal entities, site, brand relationship and buyer attendees | Written attendee and scope list |
| Permitted areas | Which production, packing, warehouse or laboratory areas may be observed | Approved route and access conditions |
| Quality workflow | How specifications, batch records, COA requests and changes are handled | Document-process explanation and follow-up list |
| Product review | Exact SKU categories and the quotation or lot stage under discussion | Product-specific questions and evidence requests |
| Close-out | Open actions, owners and dates | Written follow-up after the visit |
What should be confirmed before travel?
Appointment and access
- Written date, time and meeting point
- Attendee names and identification requirements
- Safety, clothing and photography rules
- Language and interpreter arrangement
Meeting output
- Product and lot scope
- Documents available for discussion
- Questions for production and quality teams
- Host contact and rescheduling process
